Get the latest market trends in your inbox
Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul
Tampa-St. Petersburg news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg
Rep. Anna Eshoo (D-Calif.). Photo: Tom Williams/CQ Roll Call via Getty
The advocacy group Patients for Affordable Drugs Action is launching an ad campaign today against Rep. Anna Eshoo — the first time the group has targeted a Democrat.
The big picture: According to Patients for Affordable Drugs, Eshoo has received more money from the pharmaceutical industry than any other House member. The group is spending $500,000 against her.
Why it matters: By and large, Democrats are the more anti-pharma party, so anti-pharma ads will more frequently cut against Republicans. And $500,000 is not a ton of money, especially against a many-term incumbent in a safe district.
- But health care is a personal, emotional issue for many voters. Some of President Trump's biggest fans have broken with conservative orthodoxy to back Medicare price negotiations, while some progressives distrust Sen. Cory Booker partly because of a vote against importing cheaper drugs from other countries.
- As contradictory as this sounds, health care is still a deeply partisan issue but also one where people aren't always willing to simply toe the line.